Driving the Damage
Patients with mutations in a gene called STING suffer lung disease. This study reveals cells that line vessels (endothelium) bearing the mutation are initiating the lung pathology and could be exploited as a potential treatment target
Read the published research article here
Image from work by Kevin MingJie Gao and colleagues
Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA
Image originally published with a Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Published in Cell Reports, April 2024
You can also follow BPoD on Instagram, Twitter and Facebook












